The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 421.10
Bid: 420.00
Ask: 420.10
Change: 15.40 (3.80%)
Spread: 0.10 (0.024%)
Open: 411.70
High: 421.10
Low: 409.20
Prev. Close: 405.70
RR. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Sale of L'Orange to Woodward Inc.

4 Jun 2018 07:00

RNS Number : 1150Q
Rolls-Royce Holdings plc
04 June 2018
 

4 June 2018

 

ROLLS-ROYCE COMPLETES SALE OF L'ORANGE TO WOODWARD INC

 

Rolls-Royce confirms that completion of the sale of its fuel injector business, L'Orange, a wholly owned subsidiary of Rolls-Royce Power Systems, to Colorado-based Woodward Inc. took place on 1 June. The completion of the transaction, which was announced on 9 April, followed recent clearance from the German antitrust authorities.

 

Net proceeds totalled €673m after transaction costs and other adjustments and included a cash contribution reflecting 2018 trading prior to the date of completion. In 2017, L'Orange reported pro forma sales of €244m, pro forma underlying EBITDA of €74m, pro forma underlying operating profit of €64m and pro forma post-tax free cash flow of €51m. The results of L'Orange up to the date of completion will be classified as non-core in our 2018 results and the 2017 comparative will be restated to reflect this classification.

 

L'Orange, based in Stuttgart, Germany, will remain an important partner and supplier to Rolls-Royce Power Systems through a long-term supply agreement, with an initial term of 15 years.

 

 

About Rolls-Royce Holdings plc

 

1. Rolls-Royce pioneers cutting-edge technologies that deliver the cleanest, safest and most competitive solutions to meet our planet's vital power needs.

 

2. Rolls-Royce has customers in more than 150 countries, comprising more than 400 airlines and leasing customers, 160 armed forces, 4,000 marine customers including 70 navies, and more than 5,000 power and nuclear customers.

 

3. Annual underlying revenue was £15 billion in 2017, around half of which came from the provision of aftermarket services. The firm and announced order book stood at £78.5 billion at the end of December 2017.

 

4. In 2017, Rolls-Royce invested £1.4 billion on research and development. We also support a global network of 31 University Technology Centres, which position Rolls-Royce engineers at the forefront of scientific research.

 

5. Rolls-Royce employs 50,000 people in 50 countries. More than 18,200 of these are engineers.

 

6. The Group has a strong commitment to apprentice and graduate recruitment and to further developing employee skills. In 2017 we recruited 313 graduates and 339 apprentices through our worldwide training programmes.

 

 

For further information, please contact:

 

Ross HawleyAssistant Director of Investor Relations

Rolls-Royce plc

Tel +44 (0) 20 7227 9282

ross.hawley@rolls-royce.com

 

Richard Wray

Director of External Communications

Rolls-Royce plc

Tel +44 (0) 20 7227 9163

richard.wray@rolls-royce.com

 

www.Rolls-Royce.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISKMGGVLFDGRZM
Date   Source Headline
26th Apr 20241:36 pmRNSDirector/PDMR Shareholding
10th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20241:50 pmRNSHolding(s) in Company
2nd Apr 202410:00 amRNSDirector/PDMR Shareholding
26th Mar 202411:00 amRNSDirector/PDMR Shareholding
13th Mar 20249:00 amRNSDirector/PDMR Shareholding
8th Mar 20241:45 pmRNSDirector/PDMR Shareholding
6th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 202411:30 amRNSDirector/PDMR Shareholding
29th Feb 20249:00 amRNSAGM Statement
28th Feb 20243:30 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:30 amRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSFull Year Results 2023
8th Feb 20244:00 pmRNSDirector/PDMR Shareholding
26th Jan 20243:00 pmRNSDirector/PDMR Shareholding
10th Jan 202411:45 amRNSDirector/PDMR Shareholding
21st Dec 20232:00 pmRNSDirector/PDMR Shareholding
21st Dec 20231:58 pmRNSDirector/PDMR Shareholding
20th Dec 202310:00 amRNSHolding(s) in Company
11th Dec 20233:45 pmRNSHolding(s) in Company
8th Dec 202312:00 pmRNSDirector/PDMR Shareholding
1st Dec 20234:00 pmRNSTotal Voting Rights
1st Dec 20233:50 pmRNSDirector/PDMR Shareholding
1st Dec 20233:45 pmRNSDirector/PDMR Shareholding
29th Nov 20232:15 pmRNSDirector/PDMR Shareholding
29th Nov 20231:00 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSCapital Markets Day
8th Nov 202311:30 amRNSDirector/PDMR Shareholding
30th Oct 202310:15 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSRolls-Royce creates more efficient organisation
11th Oct 20232:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20239:30 amRNSHolding(s) in Company
28th Sep 202310:30 amRNSDirector/PDMR Shareholding
11th Sep 20239:30 amRNSDirector/PDMR Shareholding
25th Aug 20232:45 pmRNSDirector/PDMR Shareholding
8th Aug 202312:30 pmRNSDirector/PDMR Shareholding
8th Aug 20239:45 amRNSDirector/PDMR Shareholding
4th Aug 202311:51 amRNSHolding(s) in Company
3rd Aug 20237:00 amRNS2023 Half Year Results
2nd Aug 20237:00 amRNSDirectorate Change
31st Jul 20239:30 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
20th Jul 20239:00 amRNSDirectorate Change
10th Jul 20233:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:32 amRNSTotal Voting Rights
28th Jun 20233:30 pmRNSDirector/PDMR Shareholding
27th Jun 202312:00 pmRNSAdmission of Shares
8th Jun 20232:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
19th May 202312:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.